Some private biobanks overinflating the value of umbilical cord blood banking in marketing to expectant parents
Regenerative medicine experts warn companies are suggesting “unrealistic” applications for umbilical cord stem cell treatments Some private UK biobanks may be misleading expectant parents about the value of storing umbilical cord blood to treat life-threatening diseases that may arise in their child in the future, reveals an investigation by The BMJ, ...